Showing results (21-30 of 81) with videos related to
Sort By:
Pageof 9
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2023
Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasmaStefan A J Buck, Peter de Bruijn, Inge M Ghobadi-Moghaddam-Helmantel, et al.Cancer Research|April 24, 2014
Influence of drug formulation on OATP1B-mediated transport of paclitaxelAnnemieke J M Nieuweboer, Shuiying Hu, Chunshan Gui, et al.Cancer Chemotherapy and Pharmacology|January 22, 2008
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatmentJoan B Heijns, Maria E L van der Burg, Teun van Gelder, et al.Journal of Pharmaceutical and Biomedical Analysis|July 25, 2009
Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometryPeter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Maja J A de Jonge, et al.Journal of Pharmaceutical and Biomedical Analysis|November 15, 2011
Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: a practical solution for non-specific bindingPeter de Bruijn, Anne-Joy M de Graan, Annemieke Nieuweboer, et al.European Journal of Clinical Pharmacology|January 15, 2016
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patientsAstrid W Oosten, João A Abrantes, Siv Jönsson, et al.British Journal of Pharmacology|September 3, 2015
Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in miceSander A Huisman, Peter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, et al.Cancer Chemotherapy and Pharmacology|October 20, 2006
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patientsWalter J Loos, Ronald de Wit, Steven J Freedman, et al.Pharmacogenomics|August 13, 2015
Predicting paclitaxel-induced neutropenia using the DMET platformAnnemieke J M Nieuweboer, Marcel Smid, Anne-Joy M de Graan, et al.Clinical Pharmacokinetics|November 6, 2016
A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer PatientsAstrid W Oosten, João A Abrantes, Siv Jönsson, et al.Pageof 9